Elevated Glucagon-like Peptide-1 Receptor Level in the Paraventricular Hypothalamic Nucleus of Type 2 Diabetes Mellitus Patients

Glucagon-like peptide-1 (GLP-1) receptor (GLP-1R) agonists have been approved for the treatment of type 2 diabetes mellitus (T2DM); however, the brain actions of these drugs are not properly established. We used post mortem microdissected human hypothalamic samples for RT-qPCR and Western blotting....

Descripción completa

Detalles Bibliográficos
Autores principales: Renner, Éva, Dóra, Fanni, Oszwald, Erzsébet, Dobolyi, Árpád, Palkovits, Miklós
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781792/
https://www.ncbi.nlm.nih.gov/pubmed/36555587
http://dx.doi.org/10.3390/ijms232415945

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781792/
https://www.ncbi.nlm.nih.gov/pubmed/36555587
http://dx.doi.org/10.3390/ijms232415945

Ejemplares similares